Model
Edge
Cidara Therapeutics Inc.
CDTX
Filing Type
10-K
Filing Date
4/21/2024
Updated
4/22/24, 2:56 PM
Filing
10-K
Earnings Release
Exhibits
10-K
FY 2023
EX-3.2
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
EX-10.5
AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
EX-23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-31.1
CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-31.2
CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-32.1
CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
EX-32.2
CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002
EX-97.1
INCENTIVE COMPENSATION RECOUPMENT POLICY
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic